Overall rank by patents
#6,500
of 49,997 tracked assignees
USPTO PatentsView assignee record - 51 granted patents across 8 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).
The verdict
According to USPTO PatentsView, Agenus ranks #6,500 of 49,997 tracked US assignees by granted-patent volume, with 51 patents across 8 technology areas.
USPTO PatentsView assignee plate
Corpus R6500 · US Corporation #6,500 · 51 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Adama Makhteshim Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Agenus · this assignee
44 score
BeiGene · near
44 score
Genethon · near
44 score
MTS Systems · near
44 score
Sequenom · near
44 score
3D Lighting… · lowest
7 score
What this shows Agenus's Innovation Score is 44.2/100 (top 26% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Agenus Inc. is a focused PatentsView assignee: 8 CPC subclasses with 100% of grants classified under C07K (Peptides). Peak complete grant year is 2020 (9 grants) versus a trough of 2 in 2017. By volume, Agenus sits between Adama Makhteshim Ltd. and Built Robotics Inc..
From 2019–2021 to 2022–2024, Agenus Inc. moved from 24 to 20 grants (0.83x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Adama Makhteshim Ltd.
51 patents
Alphatheta Corporation
51 patents
Amvac Chemical Corporation
51 patents
AST & Science, LLC
51 patents
Analytics For Life Inc.
51 patents
Bauer Maschinen GmbH
51 patents
Barracuda Networks, Inc.
51 patents
Built Robotics Inc.
51 patents
Agenus Inc.
51 patents
What this shows Agenus holds 51 patents at rank #6,503, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #6,503 in granted patent volume.
Other assignees with the most granted patents in Agenus's primary technology class.
Two PlainPatent-derived peer sets for Agenus, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (44 here).
Nearest assignees by average claims per patent (29.4 here).
Agenus's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
44 Top 26% higher than 74% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 2 | 3.9% |
| 2018 | 2 | 3.9% |
| 2019 | 6 | 11.8% |
| 2020 | 9 | 17.6% |
| 2021 | 9 | 17.6% |
| 2022 | 9 | 17.6% |
| 2023 | 5 | 9.8% |
| 2024 | 6 | 11.8% |
| 2025partial year | 3 | 5.9% |
Top 8 of 8 technology areas
Overall rank by patents
#6,500
of 49,997 tracked assignees
44.2 out of 100
What to do with this data
Agenus Inc.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.